Two Sigma Advisers »

Neurocrine Biosciences shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Neurocrine Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Neurocrine Biosciences held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurocrine Biosciences by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2012-12-31 $92k 1.2k 75.29

More positions owned by Two Sigma Advisers

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Merck & Co (MRK)
Micron Technology (MU)
Netflix (NFLX)
Paypal Holdings (PYPL)
Bristol Myers Squibb (BMY)
Qualcomm (QCOM)
Pinterest Cl A (PINS)
Meta Platforms Cl A (META)
General Motors Company (GM)

View all positions for Two Sigma Advisers

Top funds holding Neurocrine Biosciences

Vanguard Group
Bellevue Group
Jpmorgan Chase & Co
Henderson Group
T. Rowe Price Associates
Point72 Asset Management
Dodge & Cox
DSM Capital Partners
Wellington Management Company
Brown Advisory Holdings Incorporated
Bank of New York Mellon
Deerfield Management Company
Franklin Resources
Jacobs Levy Equity Management
AQR Capital Management

View all funds holding Neurocrine Biosciences